MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2017 International Congress

    Clinical and Imaging and phenoconversion in the PARS prodromal cohort

    K. Marek, A. Siderowf, S. Eberly, D. Oakes, M. Stern, D. Russell, J. Seibyl, D. Jennings (New Haven, CT, USA)

    Objective: We report clinical and imaging phenoconversion data at 6 years follow-up for the PARS cohort. Background: The PARS cohort consists of 203 hyposmic and…
  • 2017 International Congress

    Emergence of Non-motor Fluctuations with Reference to Motor Fluctuations in Parkinson’s Disease

    A. Kim, Y. Kim, A. Kim, C.W. Shin, B. Jeon, H. Kim (Seoul, Republic of Korea)

    Objective: To examine the timing of emergence of non-motor fluctuations (NMF) with reference to motor fluctuations (MF) in Parkinson’s Disease (PD). Background: NMF and MF…
  • 2017 International Congress

    Clinical correlates of severe somnolence in Parkinson’s disease: results from an international naturalistic non-motor symptoms cohort

    R. Taddei, A. Sauerbier, M. Qamar, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To compare patients with mild and severe daytime somnolence using cut-off values from item 15 of the Parkinson’s disease (PD) sleep scale (PDSS). Background:…
  • 2017 International Congress

    Non-motor symptoms in Parkinson’s disease and putamen dopamine transporter uptake (DaTscan) uptake: a survey of 85 patients

    M. Qamar, A. Sauerbier, A. Rizos, K. Chaudhuri (London, United Kingdom)

    Objective: We addressed association between 30 non-motor symptoms (NMS) (using the validated Parkinson’s disease (PD) NMS Scale (NMSS)), and DaTscan putamen uptake ratios as part…
  • 2017 International Congress

    Female reproductive factors and clinical features of PD

    H. Liu, R. Ou, Y. Hou, Q. Wei, W. Song, B. Cao, B. Zhao, H. Shang (Chengdu, China)

    Objective: The aim of this study is to explore the potential effect of reproductive factors on the clinical features of Parkinson’s disease (PD) from a…
  • 2017 International Congress

    Changes in Functioning Associated with Exercise in Individuals with Parkinson’s

    L. Clack, B. Riemann, M. Cohen (Savannah, GA, USA)

    Objective: The purpose of this study was to assess changes in physical function, cognitive function, and quality of life in individuals with Parkinson’s disease as…
  • 2017 International Congress

    Evaluating Non-Motor Fluctuations in Parkinson’s Disease Using a Visual Analogue Scale

    E. Brown, K. Dodenhoff, J. Ostrem, C. Racine (San Francisco, CA, USA)

    Objective: To further understand non-motor fluctuations (NMF) and their relationship to other symptoms of Parkinson’s disease (PD) in a deep brain stimulation (DBS) population. Background:…
  • 2017 International Congress

    Physical Activity and Quality of Life in People with Parkinson’s Disease – A Long-term Follow-up Study

    I-F. Shih, K. Paul, J. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: This study aims to examine associations between changes in physical activity (PA) and health-related quality of life (HRQOL) among Parkinson disease (PD) patients. Background:…
  • 2017 International Congress

    Does gender influence the expression of non-motor symptoms in Parkinson’s disease?: An observational study

    J. Herreros Rodríguez, A. Esquivel López, R. Gordo Mañas, Á. Sánchez Ferro (Madrid, Spain)

    Objective: Our goal was to evaluate how gender influenced the expression of non-motor symptoms in a sample of PD patients. Background: Parkinson’s Disease (PD) is defined…
  • 2017 International Congress

    Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry

    M. Schiess, J. Krauss, J.-P. Azulay, E. Cuny, A. Lopez Rios, F. Farrokhi, S. Blond, T. Witt, C. Raftopoulos, J. Vesper, B. Van Dorn, T. Weaver, P. Konrad, S. Falowski, S. Palfi (Houston, TX, USA)

    Objective: Summarize change in QoL and health status by comparing scores from the EuroQuol-five domain questionnaire, five level response version (EQ-5D-5L) summary index and Visual Analog Scale (EQ-VAS) obtained at…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley